Printer Friendly Printed from http://www.researchandmarkets.com/reports/599451 Cancer Acute Lymphoblastic Leukemia or Leukemia or Chronic Lymphocytic Leukemia or Chronic Myelogenous Leukemia or Acute Myelogenous Leukemia or Hairy Cell Leukemia Description: "Cancer Acute Lymphoblastic Leukemia or Leukemia or Chronic Lymphocytic Leukemia or Chronic Myelogenous Leukemia or Acute Myelogenous Leukemia or Hairy Cell Leukemia " contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of allergy drugs by company and by stage as well as a summary of the latest news and developments in this area. Scope of the report: Each ’ Therapy Area Pipeline Report provides the user with real detail on drug pipelines, by company and by stage, for each specific therapy area. The latest news, by company, also ensures that each report is fresh and up-to-date. In addition to new developments and disease specific pipeline projects, each report also contains extensive information in tabular format on a company’s full product pipeline and products by phase of development with regard to the therapy area. Full pipeline details, by stage, are provided and include detailed product descriptions, information on partnering activity plus clinical trial intelligence. Each Therapy Area Pipeline Report also provides detail on the top 20 companies with products in the early stage of development and the top 20 companies with products in the late stage of development. Finally, each report also provides a comparison with other major indications in the disease hub based on Marketed Products vs. Pipeline Products. Key benefits - Understand a company’s strategic position by accessing detailed independent intelligence on its product pipeline for specific therapy areas. - Keep track of your competitors and partners by better understanding their product pipeline. - Monitor a company’s research effectiveness by determining pipeline depth and number of products in development by clinical phase for specific disease areas. - Maintain a critical competitive advantage. Contents: RECENT HIGHLIGHTS AND CHANGES --Recent Highlights and Changes UPCOMING PATENT EXPIRES BY THERAPY AREA Acute Lymphoblastic Leukemia or Leukemia or Chronic Lymphocytic Leukemia or Chronic Myelogenous Leukemia or Acute Myelogenous Leukemia or Hairy Cell Leukemia Pipeline Overview --% of Projects (By Phase of Development) --No. of Projects by Phase of Development --Marketed Products Vs. Pipeline Products Company Overview - Pipeline Projects --Company Overview - Pipeline Projects --Top Companies in late stage Acute Lymphoblastic Leukemia or Leukemia or Chronic Lymphocytic Leukemia or Chronic Myelogenous Leukemia or Acute Myelogenous Leukemia or Hairy Cell Leukemia Projects --Biogen Idec Inc --Ascenta Therapeutics, Inc. --Celgene Corporation --Bristol-Myers Squibb Company --Cephalon Inc --Cell Genesys Inc --Genmab A/S --Genentech Inc --Genzyme Corporation --Genta Incorporated --Johnson & Johnson --Geron Corporation --MethylGene Inc --Merck & Co Inc --Taiho Pharmaceutical Co., Ltd. --Mundipharma International Limited --Vertex Pharmaceuticals Inc --Topotarget A/S --Xanthus Pharmaceuticals, Inc. --erly Xanthus Life Sciences) --Vion Pharmaceuticals Inc --Top Companies in early stage Acute Lymphoblastic Leukemia or Leukemia or Chronic Lymphocytic Leukemia or Chronic Myelogenous Leukemia or Acute Myelogenous Leukemia or Hairy Cell Leukemia Projects --Affimed Therapeutics AG --Aegera Therapeutics Inc. --Amgen Inc --Alexion Pharmaceuticals Inc --Ariad Pharmaceuticals Inc --AquaGenyx Pharmaceuticals Inc. --Biogen Idec Inc --AstraZeneca Plc --CSL Limited --Callisto Pharmaceuticals Inc --Genentech Inc --EntreMed Inc --MAT Biopharma --Innovive Pharmaceuticals, Inc. --Onconova Therapeutics Inc. --Novartis AG --Sanofi-Aventis --Reata Pharmaceuticals, Inc. --Targa Therapeutics Corp. --Sunesis Pharmaceuticals Inc Pipeline Revenue --Pipeline Revenue Full Pipeline View --Pre Clinical Pipeline View --Phase I Pipeline View --Phase II Pipeline View --Phase III Pipeline View --Pending Approval Pipeline View --Approved Pipeline View --On the Market Pipeline View --Discovery/Development Pipeline View Ordering: Order Online - visit http://www.researchandmarkets.com/reports/599451 Order by Fax - using the order form below Order By Post - print the order form below and send to Research and Markets, Guinness Centre, Taylors Lane, Dublin 8, Ireland. Page 1 of 2 Printed 21/08/2008 21:20:44 Fax Order Form To place an order via fax simply print this form, fill in the information below and fax the completed form to the number at the bottom of this page. If you have any questions please email help@researchandmarkets.com Order information Please verify that the product information is correct and select the format you require. Product Name: Cancer Acute Lymphoblastic Leukemia or Leukemia or Chronic Lymphocytic Leukemia or Chronic Myelogenous Leukemia or Acute Myelogenous Leukemia or Hairy Cell Leukemia Web Address: http://www.researchandmarkets.com/reports/599451 Office Code: OCHGFMMTSXZ Report formats Please enter the quantity of the report format you require. Format Quantity Price Hard Copy €1,707.00 + EUR€ 50.00 Shipping/Handling * Electronic (PDF) €1,600.00 * Shipping/Handling is only charged once per order. Contact information Please enter all the information below in BLOCK CAPITALS. First Name:   Last Name:   Email Address: Job Title: Organisation: Address: City: Postal/Zip Code: Country: Phone Number: Fax Number: Please fax this form to: (646)607-1907 or (646)964-6609 - From USA +353-1-481-1716 or +353-1-653-1571 - From Rest of World Page 2 of 2 Printed 21/08/2008 21:20:44 Payment information Please indicate the payment method you would like to use by selecting the appropriate box.  Pay by Credit Card: American Express Diners Club Master Card Visa Cardholder Name: Expiry Date: / Card Number: CVV Security Code: Issue Date: /   (Diners Club only)  Pay by Check: Please post the check, accompanied by this form, to: Research and Markets, Guinness Centre, Taylors Lane, Dublin 8, Ireland.  Pay by Wire Transfer: Please transfer funds to: Account number: 83313083 Sort code: 98-53-30 Swift code: ULSBIE2D IBAN number: IE78ULSB98533083313083 Bank Address: Ulster Bank, 27-35 Main St, Blackrock, Co. Dublin, Ireland. If you have a Marketing Code please enter it below: Marketing Code: Please note that by ordering from Research and Markets you are agreeing to our Terms and Conditions at http://www.researchandmarkets.com/info/terms.asp Please fax this form to: (646)607-1907 or (646)964-6609 - From USA +353-1-481-1716 or +353-1-653-1571 - From Rest of World